Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$117.78 - $143.9 $1.12 Million - $1.37 Million
-9,503 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$73.85 - $120.02 $37,515 - $60,970
508 Added 5.65%
9,503 $1.14 Million
Q3 2020

Nov 12, 2020

SELL
$63.15 - $77.12 $41,679 - $50,899
-660 Reduced 6.84%
8,995 $672,000
Q2 2020

Aug 13, 2020

BUY
$59.36 - $74.43 $350,580 - $439,583
5,906 Added 157.54%
9,655 $682,000
Q1 2020

May 13, 2020

BUY
$55.41 - $90.19 $48,151 - $78,375
869 Added 30.17%
3,749 $246,000
Q4 2019

Feb 14, 2020

BUY
$70.15 - $83.11 $202,032 - $239,356
2,880 New
2,880 $235,000
Q1 2019

Apr 30, 2019

SELL
$58.88 - $86.19 $301,583 - $441,465
-5,122 Closed
0 $0
Q4 2018

Feb 12, 2019

BUY
$56.97 - $77.23 $6,950 - $9,422
122 Added 2.44%
5,122 $314,000
Q3 2018

Nov 13, 2018

BUY
$52.65 - $71.9 $36,749 - $50,186
698 Added 16.23%
5,000 $360,000
Q2 2018

Aug 14, 2018

BUY
$42.2 - $53.05 $181,544 - $228,221
4,302 New
4,302 $226,000

Others Institutions Holding OMCL

About OMNICELL, Inc


  • Ticker OMCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 44,288,800
  • Market Cap $2.08B
  • Description
  • Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensi...
More about OMCL
Track This Portfolio

Track First Republic Investment Management, Inc. Portfolio

Follow First Republic Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.